Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TQC2731 Injection in Adolescents With Asthma (PK, Safety, Tolerability, Immunogenicity) Phase Ib/II
CTR20252325Phase 2Active
- Sponsor
- China Grand Pharmaceutical and Healthcare Holdings
- Start
- Jun 2025
- Modality
- IgG Antibodies → Naked Antibodies → Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of bosakitug in asthma, sponsored by China Grand Pharmaceutical and Healthcare Holdings. Started Jun 2025; status: active.
02
Drugs
bosakitug
03
Conditions
asthma
Beyond the preview
Go deeper on CTR20252325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252325.